There are 2867 resources available
1077P - An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of the advanced EGFR mutation positive non-small cell lung cancer
Presenter: Yuexiao Qi
Session: Poster session 15
1420P - The pharmacokinetics and the pharmacodynamic effect of ODM-208, an inhibitor of cholesterol side-chain cleavage enzyme (CYP11A1)
Presenter: Alice Bernard-Tessier
Session: Poster session 11
807P - Adjuvant anti-PD-1 monotherapy benefit varies across different ethnicities and melanoma subtypes
Presenter: Xue Bai
Session: Poster session 03
1078P - Correlation between T cell immunity and EGFR-TKI treatment in patients harboring EGFR driver mutation
Presenter: Atsuto Mouri
Session: Poster session 15
1421P - Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial
Presenter: Alice Bernard-Tessier
Session: Poster session 11
1079P - Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with novel actionable oncogenic driver alterations
Presenter: Teresa Beninato
Session: Poster session 15
809P - Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy
Presenter: Sarah Kay Jacques
Session: Poster session 03